UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030671
Receipt number R000035018
Scientific Title Study on the validity of rheumatoid arthritis lesion evaluation by SMI joint echo
Date of disclosure of the study information 2018/03/01
Last modified on 2023/07/10 15:46:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on the validity of rheumatoid arthritis lesion evaluation by SMI joint echo

Acronym

Validity evaluation test of SMI joint echo

Scientific Title

Study on the validity of rheumatoid arthritis lesion evaluation by SMI joint echo

Scientific Title:Acronym

Validity evaluation test of SMI joint echo

Region

Japan


Condition

Condition

Rheumatoid Arthritis

Classification by specialty

Clinical immunology Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the validity of arthritis evaluation by SMI joint echo

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Correlation between SMI method, MRI and clinical score of rheumatoid arthritis, compared with Power Doppler method

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Patients satisfying the diagnostic criteria of rheumatoid arthritis

Key exclusion criteria

Cases participating in other clinical studies

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Yu
Middle name
Last name Mori

Organization

Tohoku University Graduate School of Medicine

Division name

Department of Orthopaedic Surgery

Zip code

9808574

Address

1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi

TEL

0227177245

Email

yu-mori@med.tohoku.ac.jp


Public contact

Name of contact person

1st name Yu
Middle name
Last name Mori

Organization

Tohoku University Graduate School of Medicine

Division name

Department of Orthopeadic Surgery

Zip code

9808574

Address

1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi

TEL

0227177245

Homepage URL


Email

yu-mori@med.tohoku.ac.jp


Sponsor or person

Institute

Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB of Tohoku University Hospital

Address

1-1 Seiryo-machi, Aoba-ku, Sendai

Tel

0227284105

Email

ec@rinri.hosp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 03 Month 01 Day


Related information

URL releasing protocol

https://www.med.tohoku.ac.jp/public/doc/

Publication of results

Unpublished


Result

URL related to results and publications

https://www.med.tohoku.ac.jp/public/doc/

Number of participants that the trial has enrolled

30

Results

Analysis continues on arthritis assessment by SMI and power Doppler.

Results date posted

2022 Year 07 Month 09 Day

Results Delayed

Delay expected

Results Delay Reason

Delayed analysis

Date of the first journal publication of results


Baseline Characteristics

Before treatment of rheumatoid arthritis or before treatment change after arthritis exacerbation due to secondary invalidity

Participant flow

Joint ultrasonography in cases of rheumatoid arthritis before treatment for rheumatoid arthritis or before changing treatment after arthritis exacerbation due to secondary invalidity.

Adverse events

None

Outcome measures

Quantitative Evaluation of Synovitis by Ultrasonography

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 01 Month 04 Day

Date of IRB

2018 Year 03 Month 01 Day

Anticipated trial start date

2018 Year 03 Month 01 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry

2022 Year 03 Month 31 Day

Date trial data considered complete

2022 Year 03 Month 31 Day

Date analysis concluded

2022 Year 03 Month 31 Day


Other

Other related information

described above


Management information

Registered date

2018 Year 01 Month 04 Day

Last modified on

2023 Year 07 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035018


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name